Lido Advisors
RDHL

Lido Advisors’s Redhill Biopharma RDHL Stock Holding History

Lido Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3K Buy
+11,009
New +$10.2K ﹤0.01% 2115

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

Lido Advisors's RDHL Position: Q2 2026 in Review

Lido Advisors opened a new position in Redhill Biopharma (RDHL) in Q2 2026: 11,009 shares worth $9.3K. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings.

7 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Lido Advisors held 11,009 shares of Redhill Biopharma worth $9.3K as of Q2 2026.
  • Redhill Biopharma was a new Lido Advisors position in Q2 2026.
  • Redhill Biopharma made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #2115 holding.
  • 7 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.